These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Ebola virus shed glycoprotein is toxic to human T, B, and natural killer lymphocytes. Perez-Valencia LJ; Vannella KM; Ramos-Benitez MJ; Sun J; Abu-Asab M; Dorward DW; Awad KS; Platt A; Jacobson E; Kindrachuk J; Chertow DS iScience; 2023 Aug; 26(8):107323. PubMed ID: 37529105 [TBL] [Abstract][Full Text] [Related]
9. Estimating the serial interval of Marburg virus human-to-human transmission from a case cluster seeded by a cross-border traveller. Guo Z; Zhao S; Sun S; Wang K; Ran J; He D; Wei Y; Wang H; Sun J; Chong KC; Yeoh EK J Travel Med; 2023 Sep; 30(5):. PubMed ID: 37522757 [No Abstract] [Full Text] [Related]
10. A Review: Understanding Molecular Mechanisms of Antibody-Dependent Enhancement in Viral Infections. Sawant J; Patil A; Kurle S Vaccines (Basel); 2023 Jul; 11(7):. PubMed ID: 37515055 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of microbicidal actives and formulations for inactivation of Lassa virus in suspension. Cutts TA; Nims RW; Rubino JR; McKinney J; Kuhn JH; Ijaz MK Sci Rep; 2023 Aug; 13(1):12983. PubMed ID: 37563252 [TBL] [Abstract][Full Text] [Related]
12. Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial. Mwesigwa B; Houser KV; Hofstetter AR; Ortega-Villa AM; Naluyima P; Kiweewa F; Nakabuye I; Yamshchikov GV; Andrews C; O'Callahan M; Strom L; Schech S; Anne Eller L; Sondergaard EL; Scott PT; Amare MF; Modjarrad K; Wamala A; Tindikahwa A; Musingye E; Nanyondo J; Gaudinski MR; Gordon IJ; Holman LA; Saunders JG; Costner PJM; Mendoza FH; Happe M; Morgan P; Plummer SH; Hickman SP; Vazquez S; Murray T; Cordon J; Dulan CNM; Hunegnaw R; Basappa M; Padilla M; Gajjala SR; Swanson PA; Lin BC; Coates EE; Gall JG; McDermott AB; Koup RA; Mascola JR; Ploquin A; Sullivan NJ; Kibuuka H; Ake JA; Ledgerwood JE; Lancet Infect Dis; 2023 Dec; 23(12):1408-1417. PubMed ID: 37544326 [TBL] [Abstract][Full Text] [Related]
14. Spatial resolution of virus replication: RSV and cytoplasmic inclusion bodies. Risso-Ballester J; Rameix-Welti MA Adv Virus Res; 2023; 116():1-43. PubMed ID: 37524479 [TBL] [Abstract][Full Text] [Related]
15. Inequitable access to Ebola vaccines and the resurgence of Ebola in Africa: A state of arts review. Abdul-Rahman T; Lawal L; Meale E; Ajetunmobi OA; Toluwalashe S; Alao UH; Ghosh S; Garg N; Aborode AT; Wireko AA; Mehta A; Sikora K J Med Virol; 2023 Aug; 95(8):e28986. PubMed ID: 37534818 [TBL] [Abstract][Full Text] [Related]
16. Researching the Ebola Reservoir with the Heuristic of the Fetish in Guinea. Roth E Med Anthropol; 2023 May; 42(4):369-382. PubMed ID: 37522962 [TBL] [Abstract][Full Text] [Related]
17. Structure-Activity Relationships of Triphenylethylene Derivatives and Their Evaluation as Anticancer and Antiviral Agents. Ahmed NS; El-Nakib HE; Ramsis MM; Albably NO; Wober J; Weigand JJ; Schwedtmann K; Zierau O; Abadi AH ACS Omega; 2023 Jul; 8(29):25903-25923. PubMed ID: 37521647 [TBL] [Abstract][Full Text] [Related]